Study of the effectiveness of continuous glucose monitoring to improve intraoperative glucose management in liver transplantation: a prospective randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055236

Enrollment

Unknown

Registered

2022-01-04

Start date

2022-01-11

Completion date

Unknown

Last updated

2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

group CG :Continuous blood glucose monitoring + arterial blood gas analysis

group C:Arterial blood gas analysis

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with confirmed type 2 diabetes or preoperative HbA1C > 6.5%; 2. Orthotopic allogeneic liver transplantation is planned; 3. Aged 18-65 years; 4. ASA II-III level; 5. The patients signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. MELD score >= 30; 2. Preoperative complicated with severe infection; 3. Preoperative severe circulatory instability, manifested as unstable angina pectoris, left ventricular ejection fraction < 30%, malignant arrhythmia.

Design outcomes

Primary

Measure	Time frame
Coefficient of variation of blood glucose;	—

Secondary

Measure	Time frame
Blood glucose mean;Hypoglycemia;Hyperglycemia;Relative error;Clark error analysis;Surgical sites infections;Infections;Liver function;Severe cardiovascular events;	—

Countries

China

Contacts

Public ContactDuan Yi

Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

dya01610@btch.edu.cn+86 13810385311

Outcome results